oa Journal of Endocrinology, Metabolism and Diabetes in South Africa - Cannabinoid antagonist in obesity treatment : commentary on a clinical trial
|Article Title||Cannabinoid antagonist in obesity treatment : commentary on a clinical trial|
|© Publisher:||Medpharm Publications|
|Journal||Journal of Endocrinology, Metabolism and Diabetes in South Africa|
|Author||M-T. Van der Merwe|
|Publication Date||Jan 2009|
|Pages||112 - 113|
|Keyword(s)||Cannabinoid antagonist and Obesity treatment|
CP-945.598 is an orally active selective antagonist of the cannabinoid CB-1 receptor that has been developed for weight loss and the prevention of weight regain in obese and overweight individuals.
Article metrics loading...